[1]
M. Hałabiś, E. Kimak, and J. Solski, “Concentration of isoprostanes as a marker reflecting oxidative status in moderate dyslipidemia”, Curr. Issues Pharm. Med. Sci., vol. 25, no. 3, pp. 231–235, Jul. 2012, doi: 10.12923/j.2084-980X/25.3/a.01.